SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-049013
Filing Date
2023-02-24
Accepted
2023-02-24 17:24:34
Documents
13
Period of Report
2023-02-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d463440d8k.htm   iXBRL 8-K 35539
2 EX-3.1 d463440dex31.htm EX-3.1 189159
  Complete submission text file 0001193125-23-049013.txt   395549

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kdny-20230223.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20230223_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20230223_pre.xml EX-101.PRE 11711
7 EXTRACTED XBRL INSTANCE DOCUMENT d463440d8k_htm.xml XML 3568
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 23668775
SIC: 2834 Pharmaceutical Preparations